Lifestance Health Group, Inc. Stock Price, News & Analysis

LifeStance Health (NASDAQ: LFST), a major outpatient mental health care provider, has announced the appointment of Sarah Personette to its board of directors, effective August 22, 2025. Personette, currently CEO of Puck, brings over 20 years of experience in customer experience and technology leadership, including previous roles as Chief Customer Officer at X (formerly Twitter) and COO of Refinery29.

The appointment coincides with the departure of William Miller, who is stepping down from the board after five years of service. Miller, who serves as Wellsky Chairman and CEO, has been recognized for his contributions to advancing LifeStance's organizational mission during his tenure.

LifeStance Health (NASDAQ: LFST), a major outpatient mental healthcare provider, reported strong Q2 2025 financial results. Revenue increased 11% to $345.3 million, driven by higher visit volumes and clinician growth. The company's clinician base grew 11% to 7,708 clinicians, with a net addition of 173 clinicians in Q2.

The company significantly reduced its net loss to $3.8 million from $23.3 million year-over-year, while achieving record free cash flow of $56.6 million. Adjusted EBITDA grew 19% to $34.0 million. For FY 2025, LifeStance reiterated revenue guidance of $1.40-1.44 billion and raised Adjusted EBITDA expectations to $140-150 million.

LifeStance Health (NASDAQ:LFST) released a comprehensive survey revealing that 83% of Americans are experiencing "stressflation" - mental health impacts from financial stress driven by inflation and economic uncertainty. The study highlights a concerning trend where 60% of respondents are deterred from seeking mental health care due to financial constraints, up from 58% in 2024.

Key findings show that 47% of respondents have skipped therapy sessions due to cost, with millennials and Gen Z being most affected. However, there's a positive shift in care continuity, with 33% of patients returning to therapy within a week after a cost-related break in 2025, compared to just 8% in 2024. The survey also revealed that 93% of Americans view mental health care as equally important as physical health care.

LifeStance Health Group (NASDAQ: LFST), a leading outpatient mental health care provider, has scheduled its second quarter 2025 earnings release and conference call. The company will release its Q2 2025 financial results before market open on August 7, 2025, followed by a live earnings conference call at 8:30 a.m. Eastern Time.

Investors can join the call using the domestic dial-in number 1-800-715-9871 or international number 1-646-307-1963 with conference ID 1294873. A live audio webcast and related materials will be available through the Events and Presentations section of LifeStance's Investor Relations website, with a replay accessible after the call.

LifeStance Health Group (NASDAQ: LFST), a leading provider of outpatient mental health care, announced its participation in the 46th Annual Goldman Sachs Healthcare Conference in Miami, Florida. CEO Dave Bourdon and CFO Ryan McGroarty will present on Tuesday, June 10, 2025, at 10:40 a.m. Eastern time. The presentation, moderated by Jamie Perse, will be available via live webcast on the company's investor relations website, with a replay accessible after the event.

LifeStance Health (LFST) has appointed Vaughn Paunovich as its new Chief Technology Officer, effective June 9, 2025. Paunovich, who brings over 25 years of healthcare technology experience, will lead the company's end-to-end technology strategy. He previously served as EVP, Enterprise Platforms at Amwell and held leadership roles at UnitedHealth Group, including CIO of Optum Health.

Paunovich succeeds Pablo Pantaleoni, who is stepping down after joining in 2020 and leading the company's digital transformation efforts. The new CTO will focus on improving patient and clinician experience, increasing access to mental health services, and implementing scalable technologies aligned with LifeStance's mission of delivering virtual and in-person outpatient mental health care.

National Veterinary Associates (NVA) has announced key board appointments ahead of its planned IPO, naming Ken Burdick as Executive Chairman and Dr. Mike McFarland as Director. Burdick brings over 40 years of healthcare experience and currently serves as Executive Chairman at LifeStance Health (NASDAQ: LFST). He previously led WellCare Health Plans as CEO, delivering strong performance in revenue and profit margins before its acquisition by Centene Corporation.

Dr. McFarland contributes more than 40 years of veterinary healthcare expertise, including 11 years in senior leadership at Zoetis, Inc. and previous roles at Pfizer Animal Health. Greg Hartmann will remain on the board as a director, maintaining his investment in the company.

LifeStance Health Group (NASDAQ: LFST) reported strong Q1 2025 financial results, marking its first profitable quarter as a public company. Revenue increased 11% to $333.0 million, driven by higher visit volumes and improved revenue per visit. The company achieved a net income of $0.7 million, compared to a net loss of $21.1 million in Q1 2024. The clinician base grew 10% to 7,535, with visit volumes increasing 10% to 2.1 million. Adjusted EBITDA rose 25% to $34.6 million. LifeStance maintained its full-year 2025 guidance, expecting revenue between $1.40-1.44 billion and Adjusted EBITDA of $130-150 million. The company ended Q1 with $134.3 million in cash and $276.3 million in net long-term debt.

LifeStance Health Group (NASDAQ: LFST), a major outpatient mental health care provider, has scheduled its first quarter 2025 earnings release and conference call. The company will release Q1 2025 earnings before market opening on Wednesday, May 7, 2025, followed by a live earnings conference call at 8:30 a.m. Eastern Time.

Investors can participate by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international) using conference ID 6060781. A real-time audio webcast will be available through the Events and Presentations section of LifeStance's Investor Relations website, with related materials posted before the call. A replay will be accessible afterward on the same platform.